{"id":"https://openalex.org/W2807437271","doi":"https://doi.org/10.2147/ott.s165000","title":"A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma","display_name":"A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma","publication_year":2018,"publication_date":"2018-05-01","ids":{"openalex":"https://openalex.org/W2807437271","doi":"https://doi.org/10.2147/ott.s165000","mag":"2807437271","pmid":"https://pubmed.ncbi.nlm.nih.gov/29910621","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5987756"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s165000","doi":"https://doi.org/10.2147/ott.s165000","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165000","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42416","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=42416","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078134163","display_name":"Hui Xie","orcid":"https://orcid.org/0000-0003-4322-7267","observed_orcids":["https://orcid.org/0000-0003-4322-7267"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]},{"id":"https://openalex.org/I4210105491","display_name":"302 Military Hospital of China","ror":"https://ror.org/01pd66220","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105491"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hui Xie","raw_affiliation_strings":["Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","Tianjin's clinical research center for cancer, Tianjin, People's republic of china;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210105491","https://openalex.org/I4210160531"]},{"raw_affiliation_string":"Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Tianjin's clinical research center for cancer, Tianjin, People's republic of china;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023544250","display_name":"Shengtao Tian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105491","display_name":"302 Military Hospital of China","ror":"https://ror.org/01pd66220","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105491"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shengtao Tian","raw_affiliation_strings":["Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210105491","https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070002871","display_name":"Haipeng Yu","orcid":"https://orcid.org/0009-0003-0483-9671","observed_orcids":["https://orcid.org/0009-0003-0483-9671","https://orcid.org/0000-0002-7240-7526"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haipeng Yu","raw_affiliation_strings":["Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","Tianjin's clinical research center for cancer, Tianjin, People's republic of china;"],"raw_orcid":"https://orcid.org/0000-0002-7240-7526","affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Tianjin's clinical research center for cancer, Tianjin, People's republic of china;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090660158","display_name":"Xueling Yang","orcid":"https://orcid.org/0000-0001-5440-5351","observed_orcids":["https://orcid.org/0000-0001-5440-5351"]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xueling Yang","raw_affiliation_strings":["Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","Tianjin's clinical research center for cancer, Tianjin, People's republic of china;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Tianjin's clinical research center for cancer, Tianjin, People's republic of china;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100409697","display_name":"Jia Liu","orcid":"https://orcid.org/0000-0002-3313-7404","observed_orcids":["https://orcid.org/0000-0002-3313-7404"]},"institutions":[{"id":"https://openalex.org/I4210105491","display_name":"302 Military Hospital of China","ror":"https://ror.org/01pd66220","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105491"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jia Liu","raw_affiliation_strings":["Department of Blood Transfusion, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood Transfusion, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210105491","https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101528068","display_name":"Huaming Wang","orcid":"https://orcid.org/0000-0001-6229-7426","observed_orcids":["https://orcid.org/0000-0001-6229-7426"]},"institutions":[{"id":"https://openalex.org/I4210105491","display_name":"302 Military Hospital of China","ror":"https://ror.org/01pd66220","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105491"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huaming Wang","raw_affiliation_strings":["Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210105491","https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039096447","display_name":"Fan Feng","orcid":"https://orcid.org/0000-0001-8022-5514","observed_orcids":["https://orcid.org/0000-0001-8022-5514"]},"institutions":[{"id":"https://openalex.org/I4210105491","display_name":"302 Military Hospital of China","ror":"https://ror.org/01pd66220","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105491"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fan Feng","raw_affiliation_strings":["Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, 302nd Hospital of People's Liberation Army, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210105491","https://openalex.org/I4210160531"]}]},{"author_position":"last","author":{"id":null,"display_name":"Zhi Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802573037","display_name":"Tianjin Medical University Cancer Institute and Hospital","ror":"https://ror.org/0152hn881","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802573037"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhi Guo","raw_affiliation_strings":["Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","Tianjin's clinical research center for cancer, Tianjin, People's republic of china;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, People's Republic of China","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Department of interventional Therapy, Tianjin Medical University cancer institute and hospital, national clinical research center for cancer, Key laboratory of cancer Prevention and Therapy,","institution_ids":["https://openalex.org/I2802573037"]},{"raw_affiliation_string":"Tianjin's clinical research center for cancer, Tianjin, People's republic of china;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5039096447"],"corresponding_institution_ids":["https://openalex.org/I2802573037","https://openalex.org/I4210105491","https://openalex.org/I4210160531"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":4.9784,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.96568706,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"Volume 11","issue":null,"first_page":"3257","last_page":"3265"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apatinib","display_name":"apatinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/radiofrequency-ablation","display_name":"radiofrequency ablation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":1.0},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9829999804496765},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8769999742507935},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7049999833106995},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.7329999804496765},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C2780668389","wikidata":"https://www.wikidata.org/wiki/Q27262801","display_name":"Apatinib","level":3,"score":0.987390398979187},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9342244267463684},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.9019436240196228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7400290966033936},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6245328187942505},{"id":"https://openalex.org/C2777377203","wikidata":"https://www.wikidata.org/wiki/Q1809554","display_name":"Radiofrequency ablation","level":3,"score":0.6174731850624084},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.4340105354785919},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.42612290382385254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3941690921783447},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35082006454467773},{"id":"https://openalex.org/C2778902805","wikidata":"https://www.wikidata.org/wiki/Q322177","display_name":"Ablation","level":2,"score":0.3274948000907898},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3065635561943054},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.22413402795791626},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.12030205130577087}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/ott.s165000","doi":"https://doi.org/10.2147/ott.s165000","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165000","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42416","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4953248","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5987756","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:29910621","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29910621","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5987756","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5987756/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:0136f703abcf4bb1bda8e0a1d4db9a3d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0136f703abcf4bb1bda8e0a1d4db9a3d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 11, Pp 3257-3265 (2018)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/38629","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/a-new-apatinib-microcrystal-formulation-enhances-the-effect-of-radiofr-peer-reviewed-article-OTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ott.s165000","doi":"https://doi.org/10.2147/ott.s165000","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165000","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42416","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3906884130","display_name":null,"funder_award_id":"81471761","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G8155064314","display_name":null,"funder_award_id":"81501568","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2807437271.pdf","grobid_xml":"https://content.openalex.org/works/W2807437271.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1548590980","https://openalex.org/W1821077834","https://openalex.org/W2153532559","https://openalex.org/W2182442945","https://openalex.org/W2195252817","https://openalex.org/W2282155564","https://openalex.org/W2291753645","https://openalex.org/W2292523422","https://openalex.org/W2296789833","https://openalex.org/W2340445357","https://openalex.org/W2472375270","https://openalex.org/W2560499218","https://openalex.org/W2568848713","https://openalex.org/W2571717028","https://openalex.org/W2575336928","https://openalex.org/W2583476092","https://openalex.org/W2586153457","https://openalex.org/W2586794315","https://openalex.org/W2610089667","https://openalex.org/W2611767388","https://openalex.org/W2727700849","https://openalex.org/W2744717609","https://openalex.org/W2748933803","https://openalex.org/W2749365479","https://openalex.org/W2754555655","https://openalex.org/W2756380425","https://openalex.org/W2758014890","https://openalex.org/W2762903402","https://openalex.org/W2767896549","https://openalex.org/W2768054876","https://openalex.org/W2776719494","https://openalex.org/W2782500189","https://openalex.org/W2782884500","https://openalex.org/W2784264033","https://openalex.org/W2793246436","https://openalex.org/W2794353845","https://openalex.org/W2911778105","https://openalex.org/W4210955410","https://openalex.org/W4324262440"],"related_works":["https://openalex.org/W2328251033","https://openalex.org/W2182442945","https://openalex.org/W1990730061","https://openalex.org/W3037482214","https://openalex.org/W2476823408","https://openalex.org/W1973594979","https://openalex.org/W7096687579","https://openalex.org/W2112391258","https://openalex.org/W4307553637","https://openalex.org/W7136177684"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Radiofrequency":[1],"ablation":[2],"(RFA)":[3],"is":[4],"the":[5,42,119,135,171],"foremost":[6],"treatment":[7],"option":[8],"for":[9,89,125,164],"advanced":[10,90],"hepatocellular":[11],"carcinoma":[12],"(HCC),":[13],"however,":[14],"rapid":[15],"and":[16,57,115,168],"aggressive":[17],"recurrence":[18,43],"of":[19,32,44,47,60,122,138,154,174],"HCC":[20,91,101,123,131],"often":[21],"occurs":[22],"after":[23],"RFA":[24,33,139,175],"due":[25],"to":[26,158],"epithelial-mesenchymal":[27,120],"transition":[28,121],"process.":[29],"Although":[30],"combination":[31],"with":[34],"sorafenib,":[35],"a":[36,53,84,150,165],"molecular":[37,49,86],"targeted":[38,50,87],"agent,":[39,88],"could":[40,169],"attenuate":[41],"HCC,":[45],"application":[46],"this":[48,71],"agent":[51],"poses":[52],"heavy":[54],"medical":[55],"burden":[56],"oral":[58],"administration":[59],"sorafenib":[61],"also":[62],"brings":[63],"severe":[64],"side":[65],"effects.":[66],"MATERIALS":[67],"AND":[68],"METHODS:":[69],"In":[70],"study,":[72],"we":[73,146],"prepared":[74],"an":[75],"apatinib":[76,95,111,157],"microcrystal":[77],"formulation":[78],"(Apa-MS)":[79],"that":[80,107,148],"sustainably":[81],"releases":[82],"apatinib,":[83,155],"novel":[85],"treatment.":[92,140],"We":[93],"injected":[94],"solution":[96],"or":[97],"Apa-MS":[98,108,133],"into":[99],"subcutaneous":[100],"tumors.":[102],"RESULTS:":[103],"It":[104],"was":[105],"found":[106],"exhibited":[109],"slow":[110,151],"release":[112],"in":[113,116,129,161],"vivo":[114],"turn":[117],"inhibited":[118],"cells":[124],"extended":[126],"time.":[127],"Moreover,":[128],"rodent":[130],"model,":[132],"enhanced":[134],"antitumor":[136,172],"effect":[137,173],"CONCLUSION:":[141],"Based":[142],"on":[143,176],"these":[144],"results,":[145],"conclude":[147],"Apa-MS,":[149],"releasing":[152],"system":[153],"allows":[156],"remain":[159],"effective":[160],"tumor":[162],"tissues":[163],"long":[166],"time":[167],"enhance":[170],"HCC.":[177]},"counts_by_year":[{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":9}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-06-13T00:00:00"}